ArticlemedRxiv : the preprint server for health sciences2023

Pembrolizumab alters the tumor immune landscape in a patient with dMMR glioblastoma.

Todd Bartkowiak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.